(N-stearyl, norleucine¹⁷) VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist

By Moody Terry   Jensen Robert   Fridkin Mati   Gozes Illana  

Journal of Molecular Neuroscience, Vol. 18, Iss. 1-2, 2002-02 ,pp. : 29-35

Humana Press, Inc

Access to resources Recommend Favorite

Vasoactive Intestinal Peptide (VIP) Regulates Activity-Dependent Neuroprotective Protein (ADNP) Expression In Vivo

By  

Journal of Molecular Neuroscience, Vol. 33, Iss. 3, 2007-11 ,pp. : 278-283

Humana Press, Inc

Access to resources Recommend Favorite

Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC₁R)

By Knudsen Sanne   Tams Jeppe   Fahrenkrug Jan  

Journal of Molecular Neuroscience, Vol. 14, Iss. 3, 2000-06 ,pp. : 137-146

Humana Press, Inc

Access to resources Recommend Favorite

A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells

By Sharma Anita   Walters James   Gozes Yehoshua   Fridkin Mati   Brennman Douglas   Gozes Illana   Moody Terry  

Journal of Molecular Neuroscience, Vol. 17, Iss. 3, 2001-12 ,pp. : 331-339

Humana Press, Inc

Access to resources Recommend Favorite

Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome

By Hill J.M.   Ades A.M.   McCune S.K.   Sahir N.   Moody E.M.   Abebe D.T.   Crnic L.S.   Brenneman D.E.  

Experimental Neurology, Vol. 183, Iss. 1, 2003-09 ,pp. : 56-65

Elsevier

Access to resources Recommend Favorite